🇺🇸 FDA
Patent

US 7438931

Methods and compositions for the treatment of angiogenic diseases

granted A61KA61K31/28A61K33/243

Quick answer

US patent 7438931 (Methods and compositions for the treatment of angiogenic diseases) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Oct 21 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/28, A61K33/243, A61K33/34, A61K45/06